alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 31.1**

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

 

I, Nate Engel, certify that:

 

1. I have reviewed this Form 10-K/A of International Endeavors Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods present in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c) Disclosed in this report any change in the small business issuer's internal control over financing reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

 

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.

 

  

----
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 12, 2010, Noramco Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801-4417, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug
ScheduleCodeine-N-oxide (9053)
IDihydromorphine (9145)
IMorphine-N-oxide (9307)
IMethylphenidate (1724)
IICodeine (9050)
IIDihydrocodeine (9120)
IIOxycodone (9143)
IIHydromorphone (9150)
IIHydrocodone (9193)
IIMorphine (9300)
IIThebaine (9333)
IIOpium extracts (9610)
IIOpium fluid extract (9620)
IIOpium tincture (9630)
IIOpium, powdered (9639)
IIOpium, granulated (9640)
IIOxymorphone (9652)
IINoroxymorphone (9668)
IITapentadol (9780)
II
 The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substance, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administrator, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 20, 2010. Dated: October 8, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2010-26456 Filed 10-19-10; 8:45 am] BILLING CODE 4410-09-P
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANTTO SECURITIES AND EXCHANGE ACT RULE 13A-14(A)/15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.

 

CERTIFICATE OF CHIEF FINANCIAL OFFICER

 

ELITESOFT GLOBAL, INC.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of AmericaTowne,Inc. on Form 10-K for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof(the “Report”), I, Khoo Mae Ling, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)	     The Report fully complies with the requirementsof section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)	     The information contained in the Reportfairly presents, in all material respects, the financial condition and results of operations of the Company.

 

(3)	     A signed original of this written statementrequired by Section 906 has been provided to the Secretary for EliteSoft Global, Inc., and will be retained by the company andfurnished to the Securities and Exchange Commission or its staff upon request.

 

Dated: April 12, 2016

 

By: /s/ Khoo Mae Ling

Khoo Mae Ling

Chief Financial Officer

(Principal Financial Officer)
#### IN THE MATTER OF KAREN CURRY, CHARGED WITH CONTEMPT OF COURT.

February 27, 1987.

Petition for certification denied.
Exhibit 31.1

CERTIFICATION

I, Jennifer M. Davis,
certify that:

1. I have reviewed this report on Form 10-K and all reports on Form 10-D required to be filed in respect of the period
covered by this report on Form 10-K of Santander Drive Auto Receivables Trust 2014-3 (the Exchange Act periodic reports);

2.
Based on my knowledge, the Exchange Act periodic reports, taken as a whole, do not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, all of the distribution,
servicing and other information required to be provided under Form 10-D for the period covered by this report is included in the Exchange Act periodic reports;

4. I am responsible for reviewing the activities performed by the servicer and based on my knowledge and the compliance review conducted
in preparing the servicer compliance statement required in this report under Item 1123 of Regulation AB, and except as disclosed in the Exchange Act periodic reports, the servicer has fulfilled its obligations under the servicing agreement in
all material respects; and

5. All of the reports on assessment of compliance with servicing criteria for asset-backed securities and their
related attestation reports on assessment of compliance with servicing criteria for asset-backed securities required to be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18 have been
included as an exhibit to this report, except as otherwise disclosed in this report. Any material instances of noncompliance described in such reports have been disclosed in this report on Form 10-K.

In giving the certifications above, I have reasonably relied on information provided to me by the following unaffiliated parties: U.S. Bank,
National Association.



/s/ Jennifer M. DavisName:

Jennifer M. DavisTitle:

Deputy Chief Financial OfficerDate:

March 29, 2016
Exhibit 13.1





Certification Pursuant to 18 U.S.C. Section 1350





Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Check-Cap Ltd. (the “Company”), does hereby certify, to such officer’s knowledge, that:





The Annual Report on Form 20-F for the year ended December 31, 2014 of the Company fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.





CHECK-CAP LTD.April 29, 2015
By:
/s/ Guy NeevName:
Guy NeevTitle:
Chief Executive Officer and Director(Principal Executive Officer)April 29, 2015
By:
/s/ Lior ToremName:
Lior ToremTitle:
Chief Financial Officer(Principal Financial Officer

and Principal Accounting Officer)
#### STATE OF NEW JERSEY v. MARIO T. DE FELICE, JR.

November 10, 1986.

Petition for certification denied.
EXHIBIT 31.2Cronos Global Income Fund XIV, L.P.Rule 13a-14 CERTIFICATION     I, John Kallas, certify that:     1. I have reviewed this quarterly report on Form 10-Q of Cronos Global Income Fund XIV, L.P.(the “Partnership”);     2. Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to the periodcovered by this quarterly report;     3. Based on my knowledge, the financial statements, and other financial information includedin this quarterly report, fairly present in all material respects the financial condition, resultsof operations and cash flows of the Partnership as of, and for, the periods presented in thisquarterly report;     4. The other certifying officer of Cronos Capital Corp. (“CCC”), the General Partner of thePartnership, and I are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Partnership and wehave:          (a) designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe Partnership, including its consolidated subsidiaries, is made known to us by others withinthose entities, particularly during the period in which this quarterly report is being prepared;and          (b) evaluated the effectiveness of the Partnership’s disclosure controls and procedures andpresented in this quarterly report our conclusions about the effectiveness of the disclosurecontrols and procedures, based on our evaluation; and          (c) disclosed in this quarterly report any change in the Partnership’s internal control overfinancial reporting that occurred during the Partnership’s most recent fiscal quarter (thePartnership’s fourth fiscal quarter in the case of an annual report) that has materially affected,or is reasonably likely to materially affect, the Partnership’s internal control over financialreporting.     5. CCC’s other certifying officer and I have disclosed, based on our most recent evaluationof internal control over financial reporting, to the Partnership’s auditors and the Audit Committeeof Partnership’s Board of Directors (or persons performing the equivalent function):          (a) all significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affect thePartnership’s ability to record, process, summarize and report financial information; and          (b) any fraud, whether or not material, that involves management or other employees who havea significant role in the Partnership’s internal control over financial reporting.      Date: May 15, 2006     /s/ JOHN KALLAS     John Kallas  Vice President and  Chief Financial Officer of CCC
EXHIBIT 32.2

CERTIFICATION OF PERIODIC REPORT

In connection with the Quarterly Report of Dynacq Healthcare, Inc. (the
Company) on Form 10-Q for the quarterly period ended February 28, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Philip S. Chan, Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

April 14, 2009



|                       
|-----------------------
|/s/ Philip S. Chan     
|Philip S. Chan         
|Chief Financial Officer

This certification is made solely pursuant to the requirement of Section 1350 of 18 U.S.C., and is not for
any other purpose.
<PAGE>

                                                                Exhibit 32.1



                          CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350,
                           AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Zoltek Companies, Inc. (the
"Company") on Form 10-Q for the period ending March 31, 2005 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Zsolt Rumy, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:

                  (1)      The Report fully complies with the requirements
                           of section 13(a) or 15(d) of the Securities
                           Exchange Act of 1934; and

                  (2)      The information contained in the Report fairly
                           presents, in all material respects, the financial
                           condition and results of operations of the
                           Company.



Date: May 20, 2005                           By:       /s/ ZSOLT RUMY
      ------------                              -------------------------------
                                                         Zsolt Rumy
                                                   Chief Executive Officer
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

MICHAEL GLIDDEN, DOC #C03866, )

)

Appellant, )

)

v. ) Case No. 2D18-733

)

STATE OF FLORIDA, )

)

Appellee. )

)

Opinion filed November 30, 2018.

Appeal pursuant to Fla. R. App. P. 

9.141(b)(2) from the Circuit Court for Pasco 

County; Susan G. Barthle, Judge.

PER CURIAM.

Affirmed.

CASANUEVA, SLEET, and BADALAMENTI, JJ., Concur.
#### STATE OF NEW JERSEY v. ROCCO PESCATORE, ET AL.

December 16, 1986.

Petition for certification granted. (See 213 *N.J.Super.*22)
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

MIXON JUSTE

, Appellant,

v.

STATE OF FLORIDA

, Appellee

.

No. 4D 17

- 1849

[September 20, 2017 ]

Appeal of order denying rule 3.850 motion from the Circuit Court for

the Seventeenth Judicial Circuit, Broward County ; Dennis D. Bailey

, Judge; L.T. Case No. 11

- 726CF10A

.

Mixon Juste, Jasper, pro se.

No appearance required for appellee.

P ER C URIAM

.

Affirmed.

G ROSS

, C IKLIN and K UNTZ , JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 21-1343

SABRINA D. DAVIS,

Plaintiff - Appellant,

v.

BANKERS LIFE AND CASUALTY COMPANY,

Defendant - Appellee.

Appeal from the United States District Court for the District of South Carolina, at 

Greenville. Timothy M. Cain, District Judge. (6:20-cv-04130-TMC)

Submitted: September 9, 2021 Decided: September 13, 2021

Before MOTZ, KING, and WYNN, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Sabrina D. Davis, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Sabrina D. Davis appeals the district court’s order accepting the recommendation of 

the magistrate judge and dismissing Davis’ civil action related to a life insurance claim. 

We have reviewed the record and find no reversible error. Accordingly, we affirm the 

court’s order. Davis v. Bankers Life & Cas. Co., 6:20-cv-04130-TMC (D.S.C. Mar. 9, 

2021). We dispense with oral argument because the facts and legal contentions are 

adequately presented in the materials before this court and argument would not aid the 

decisional process.

AFFIRMED
file: Board Terms graphic.xlsx

tab: Sheet1

Antonio C. Amador 

(Nov '90 - Mar '97)

Samuel W. Bogley 

(Nov '88 - Nov '89)

Dennis M. Devaney 

(Aug '82 - Mar '88)

Herbert E. Ellingwood 

(Dec '81 - Mar '86)

Ben L. Erdreich 

(Jul '93 - Mar '00)

Susan Tsui Grundmann 

(Nov '09 - Jan '17)

Maria L. Johnson 

(May '83 - Mar '90)

Daniel R. Levinson 

(Aug '86 - Mar '93)

Susanne T. Marshall 

(Nov '97 - Mar '05)

Neil A.G. McPhie 

(Apr '03 - Nov '09)

Jessica L. Parks 

(May '90 - Mar '95)

Ersa H. Poston 

(Jan '79 - May '83)

Ruth T. Prokop 

(Jan '79 - Jun '81)

Mark A. Robbins 

(May '12 - Mar '19)

Mary M. Rose 

(Dec '05 - Mar '12)

Barbara J. Sapin 

(Dec. '00 - Dec. '01; 

Nov. '04 - Feb. '08)

Beth S. Slavet 

(Aug '95 - Mar '03)

Anne M. Wagner 

(Nov '09 - Mar '15)

Ronald P. Wertheim 

(Oct '79 - Jan '82)

term vacancy 

(Mar '15-Mar '21)

vacant 

(Mar '19-Mar '22)

lack quorum begins 

(Jan '17-Mar '22)

vacancy 

(Mar '21 -present)

Tristan L. Leavitt 

(Mar '22- )

Raymond A. Limon 

(Mar '22- )

1978 1981 1984 1987 1990 1993 1996 1999 2002 2005 2008 2011 2014 2017 2020 2023 2026 2029 2032

Merit Systems Protection Board 

Board Members' Service

January 1979 - March 2022
#### STATE OF NEW JERSEY v. SHARON WEILER.

November 10, 1986.

Petition for certification denied. (See 211 *N.J.Super.*602)
**Exhibit 32.1**

 

**CERTIFICATION OF DISCLOSURE PURSUANTTO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACTOF 2002**

 

In connection with the Annual Report ofSoutheastern Holdings, Inc. (the "Company") on Form 10-K/A for the period ending December 31, 2016 as filed with the Securitiesand Exchange Commission on the date hereof (the "Report") I, Paul Dickman, Chief Executive Officer and Principal ExecutiveOfficer of the Company, certify, pursuant to 18 USC section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Actof 2002, that to the best of my knowledge and belief:

 

(1) The Report fullycomplies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information containedin the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: August 15, 2018

 

/s/ Paul Dickman                                     

Paul Dickman,

Chief Executive Officer, Principal ExecutiveOfficer

 

This certification accompanies the Reportpursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Actof 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
# Sitemap

## February 26, 2016

- Home
- Sitemap
- 2016
- 02
- February 26, 2016

            - NASA Talk Hopes to Communicate the “Science” in Science Communication
            - NASA Astronaut Scott Kelly, Researchers Available to Discuss One-Year Mission
            - Front Entrance from the Inside of Building 226
            - Aspiring Young Researchers Help NASA Solve Aviation Challenges
            - Media Accreditation Open for Space Station Crew News Conference, Interviews
            - NASA’s Science Command Post Supports Scott Kelly’s Year In Space
            - NASA’s IBEX Observations Pin Down Interstellar Magnetic Field
            - Hubble’s Blue Bubble
            - Sols 1266-1268: Taking Stock of Stockdale
EX-10.2





			
	



	  	Exhibit 10.2

 December 8, 2021 

Mr. Vernon Irvin 
 Address 

Address 
 Dear Vernon: 

This letter sets forth the terms under which you will assume the position of Interim Co-Chief Executive Officer of
Everbridge, Inc. (the “Company”). You also will retain your current position of Chief Revenue Officer of the Company. During the period in which you are serving as Interim Co-Chief Executive Officer
and for three months thereafter, you will receive a monthly stipend of $25,000 in addition to your current Base Salary. In your capacity as Interim Co-Chief Executive Officer, you will perform such duties and
have such responsibilities as may be assigned to you from time to time by the Board of Directors of the Company. 
 On or about January 1, 2022, you
will receive two grants of Restricted Stock Units under the Company’s 2016 Equity Incentive Plan, each with a value of $2,500,000 based on the closing price of a share of Everbridge common stock on the Nasdaq Global Market on the date of grant.
The first of such $2,500,000 RSU grants (the “18-Month RSUs”) will vest as follows: 
  

	 	•	 	 75% of the 18-Month RSUs will vest on the last day of the month in which
occurs the one-year anniversary of the grant date; and 


  

	 	•	 	 25% of the 18-Month RSUs will vest on the last day of the month in which
occurs the 18-month anniversary of the grant date. 


 The second of such $2,500,000 RSU grants
(the “3-Year RSUs) will vest as follows: 
  

	 	•	 	 33% of the 3-Year RSUs will vest on the last day of the month in which
occurs the one-year anniversary of the grant date; 


  

	 	•	 	 33% of the 3-Year RSUs will vest on the last day of the month in which
occurs the two-year anniversary of the grant date; and 


  

	 	•	 	 34% of the 3-Year RSUs will vest on the last day of the month in which
occurs the three-year anniversary of the grant date. 


 All of your other existing equity grants
will continue to vest in accordance with their terms. 
 All other terms of your employment agreement with the Company dated August 19, 2019 (the
“Agreement”) remain unchanged. Capitalized terms used without definition herein shall have the meaning assigned to such terms in the Agreement. 
  

  
 WWW.EVERBRIDGE.COM 













 Mr. Vernon Irvin 

December 8, 2021 
 Page 2 

 

 Please sign below to indicate your agreement with the terms of this letter. 

Very truly yours, 
  

			
	 EVERBRIDGE, INC.

		
	 By:
	 	 /s/ Jaime Ellertson

		 	 Jaime Ellertson

		 	 Chairman of the Board

	
	 ACCEPTED AND AGREED TO BY:

	
	 /s/ Vernon Irvin

	 Vernon Irvin

	
	 Date: December 8, 2021